title: Diffuse large B cell lymphomas relapsing in the CNS lack oncogenic MYD88 and CD79B mutations.
authors.affiliation: Department of Hematology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
authors.forename: M J
authors.initials: MJ
authors.lastname: Kersten
authors.affiliation: Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
authors.forename: W
authors.initials: W
authors.lastname: Kraan
authors.affiliation: Department of Hematology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.
authors.forename: J
authors.initials: J
authors.lastname: Doorduijn
authors.affiliation: Department of Neurology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.
authors.forename: J
authors.initials: J
authors.lastname: Bromberg
authors.affiliation: Department of Pathology, Erasmus Medical Center Rotterdam, Rotterdam, The Netherlands.
authors.forename: K
authors.initials: K
authors.lastname: Lam
authors.affiliation: Department of Pathology, University Medical Center, Groningen, The Netherlands.
authors.forename: P M
authors.initials: PM
authors.lastname: Kluin
authors.affiliation: HOVON Data Center, Erasmus MC Cancer Institute-Clinical Trial Center, Rotterdam, The Netherlands.
authors.forename: B J
authors.initials: BJ
authors.lastname: van der Holt
authors.affiliation: Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
authors.forename: M
authors.initials: M
authors.lastname: Spaargaren
authors.affiliation: Department of Pathology, Academic Medical Center, University of Amsterdam, Amsterdam, The Netherlands.
authors.forename: S T
authors.initials: ST
authors.lastname: Pals
mesh_terms: D058846:Antibodies, Monoclonal, Murine-Derived / Q000008:administration & dosage; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000008:administration & dosage; D001932:Brain Neoplasms / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D051925:CD79 Antigens / Q000235:genetics*; D002945:Cisplatin / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D003907:Dexamethasone / Q000008:administration & dosage; D005260:Female; D006801:Humans; D016403:Lymphoma, Large B-Cell, Diffuse / Q000188:drug therapy / Q000235:genetics* / Q000473:pathology; D008297:Male; D008727:Methotrexate / Q000008:administration & dosage; D008875:Middle Aged; D009154:Mutation; D053594:Myeloid Differentiation Factor 88 / Q000235:genetics*; D009363:Neoplasm Proteins / Q000235:genetics*; D000069283:Rituximab
chemical_list: D058846:Antibodies, Monoclonal, Murine-Derived; D051925:CD79 Antigens; C497883:CD79B protein, human; C507779:MYD88 protein, human; D053594:Myeloid Differentiation Factor 88; D009363:Neoplasm Proteins; D003561:Cytarabine; D000069283:Rituximab; D003907:Dexamethasone; D002945:Cisplatin; D008727:Methotrexate